In an era defined by rapid technological advancement and profound political polarization, the way Americans consume and...
Dwi Wanna
NORMAN, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...
By Douglas Feil, NBCF Chief Program Officer The burgeoning popularity of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, primarily...
Written by Douglas Feil, NBCF Chief Program Officer Medical Disclaimer: The information provided in this article is...
In a significant move to overhaul the regulatory landscape for orphan drug development, the U.S. Food and...
For many individuals, the conclusion of active breast cancer treatment—be it surgery, chemotherapy, or radiation—is often framed...
In a significant move that underscores the burgeoning intersection of artificial intelligence and clinical diagnostics, San Francisco-based...
NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a...
Age-related hearing loss, medically termed presbycusis, has long been treated as a monolithic condition in both clinical...
ROCKVILLE, MD – [Insert Date] – MacroGenics, Inc., a biopharmaceutical company dedicated to developing innovative cancer therapies,...
